argenx SE (ARGNF)
OTCMKTS · Delayed Price · Currency is USD
833.50
0.00 (0.00%)
At close: Oct 6, 2025
argenx SE Market Cap
argenx SE has a market cap or net worth of $49.16 billion as of October 9, 2025. Its market cap has increased by 50.82% in one year.
Market Cap
49.16B
Enterprise Value
45.33B
Revenue
3.12B
Ranking
n/a
PE Ratio
38.39
Stock Price
$833.50
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 166.50M to 49.16B, an increase of 29,422.10%. That is a compound annual growth rate of 65.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 49.16B | 31.08% |
| Dec 31, 2024 | 37.50B | 67.18% |
| Dec 29, 2023 | 22.43B | 8.92% |
| Dec 30, 2022 | 20.59B | 11.15% |
| Dec 31, 2021 | 18.53B | 32.86% |
| Dec 31, 2020 | 13.95B | 102.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 679.59M |
| Glass House Brands | 638.25M |
| Veradigm | 522.72M |
| Northwest Biotherapeutics | 373.50M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 331.81M |
| American Oncology Network | 287.67M |
| Silence Therapeutics | 247.98M |